Skip to main content
Premium Trial:

Request an Annual Quote

RxGenomix, Coriell Life Sciences Form PGx Alliance

NEW YORK (GenomeWeb) — RxGenomix has partnered with Coriell Life Sciences (CLS) to offer a pharmacogenomics training, implementation, and management package to healthcare providers, the companies said today.

Under the terms of the alliance, the firms will combine Franklin, Tennessee-based RxGenomix's pharmacogenomics training and implementation program with CLS' bioinformatic services for risk analysis, reporting, and population-level healthcare analytics.

Additional terms were not disclosed.

"CLS brings the right mix of analytics capabilities along with rich scientific decision support, which accelerates RxGenomix's ability to deploy the most comprehensive and effective PGx offering in healthcare," RxGenomix COO Blake Keller said in a statement.

In late 2017, Philadelphia-based CLS signed an agreement with Ovation to integrate their respective data management and reporting technologies into a single platform.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.